Back

Introduction - Cardiovascular risk in diabetes and cardiovascular outcomes trials - Where do we come from?

28 August 2016 (18:30 - 18:45)
Organised by:
Congress Presentation Part of: Addressing cardiovascular risk in type 2 diabetes - The LEADER trial Diabetes management ESC Premium Access ESC Congress 2016

About the speaker

Photo
Professor Lars Ryden

Karolinska Institute, Stockholm (Sweden)

4 More presentations in this session

Presentation thumbnail
LEADER – Cardiovascular outcomes & the cardiologist’s perspective.
Professor S. Nissen (Cleveland, US)
Presentation thumbnail
LEADER from the diabetologist’s perspective.
Professor J. Petrie (Glasgow, GB)
Presentation thumbnail
Cardiovascular outcomes trials in diabetes – What have we learned?
Doctor M. Husain (Toronto, CA)
Presentation thumbnail
Question and answers - Addressing cardiovascular risk in type 2 diabetes - The LEADER trial.
Professor L. Ryden (Stockholm, SE)

Access the full session

Session thumbnail
Addressing cardiovascular risk in type 2 diabetes - The LEADER trial

The Event

Event poster

ESC Congress 2016

28 August 2016 18:30 CET
You may be interested in
thumbnail
Webinar
EAPC Webinar: Type 2 Diabetes and cardiovascular risk
12 March 2019
thumbnail
Congress Presentation
Absolute treatment effects of novel oral antidiabetic drugs on cardiovascular mortality and hospitalization for heart failure: a meta-analysis of digitalized individual patient outcomes
27 August 2022
thumbnail
Congress Session
GLP-1 RAs: more than just glucose-lowering agents
28 August 2022
thumbnail
Congress Presentation
Real world risk of major outcomes for type 2 diabetes with stable coronary artery disease without prior MI or stroke and THEMIS-like patients using the SNDS French nationwide claims database
30 August 2020

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources